Gregory Conko and Henry Miller on the FDA vs. Doctors and Patients
The ability of physicians to prescribe approved medicines for purposes not sanctioned by the Food and Drug Administration is one of the most important elements of medical care in the United States. These "off-label" uses are perfectly legal, and doctors rely on them extensively. But the FDA views off-label prescribing as an attempt to circumvent its control over the nation's pharmaceutical supply and has put a number of restrictions in place that hurt both doctors and patients.
The most prominent rule entirely forbids drug manufacturers from promoting off-label uses. But that might change soon, however, reports Gregory Conko and Henry Miller, because two different federal courts are now considering lawsuits challenging the constitutionality of the off-label promotion ban. And given a string of recent Supreme Court cases affirming commercial free speech rights, one of those cases may at least partially invalidate the FDA's restrictions.
Hide Comments (0)
Editor's Note: As of February 29, 2024, commenting privileges on reason.com posts are limited to Reason Plus subscribers. Past commenters are grandfathered in for a temporary period. Subscribe here to preserve your ability to comment. Your Reason Plus subscription also gives you an ad-free version of reason.com, along with full access to the digital edition and archives of Reason magazine. We request that comments be civil and on-topic. We do not moderate or assume any responsibility for comments, which are owned by the readers who post them. Comments do not represent the views of reason.com or Reason Foundation. We reserve the right to delete any comment and ban commenters for any reason at any time. Comments may only be edited within 5 minutes of posting. Report abuses.
Please
to post commentsMute this user?
Ban this user?
Un-ban this user?
Nuke this user?
Un-nuke this user?
Flag this comment?
Un-flag this comment?